Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2012
10/11/2012US20120258490 Process for producing dipeptides or dipeptide derivatives
10/11/2012US20120258453 Nucleic acid probe-based diagnostic assays targeting ssra genes of prokaryotic and eukaryotic organisms
10/11/2012US20120258176 Nanoparticles for protein drug delivery
10/11/2012US20120258160 Chemically modified cellulose fibrous meshes for use as tissue engineering scaffolds
10/11/2012US20120258149 Methods and Compositions for the Prevention and Treatment of Influenza
10/11/2012US20120258148 Endosseous implant
10/11/2012US20120258147 Method for inhibiting angiogenesis
10/11/2012US20120258144 SUPPRESSORS OF CpG OLIGONUCLEOTIDES AND METHODS OF USE
10/11/2012US20120258120 Compositions and methods for the systemic treatment of arthritis
10/11/2012US20120258116 Method for inducing cancer cell apoptosis or inhibiting the cancer cell migration
10/11/2012US20120258115 Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms
10/11/2012US20120258114 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
10/11/2012US20120258111 Compositions and methods for modulating rsv infection and immunity
10/11/2012US20120258104 Delivery System and Conjugates For Compound Delivery Via Naturally Occurring Intracellular Transport Routes
10/11/2012US20120258102 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibodies
10/11/2012US20120258101 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody
10/11/2012US20120258099 Inhibitors of guanine exchange factors and their use as anticancer drugs
10/11/2012US20120258094 Method for treating a rheumatic disease using a soluble ctla4 molecule
10/11/2012US20120258093 Vla-4 as a biomarker for prognosis and target for therapy in duchenne muscular dystrophy
10/11/2012US20120258090 Method for production of recombinant human thrombin
10/11/2012US20120258089 Soluble beta-n-acetylglucosaminidase based antibiofilm compositions and uses thereof
10/11/2012US20120258088 Chimeric bacteriophage lysin with activity against staphylococci bacteria
10/11/2012US20120258087 Isotonic beverage with chelates
10/11/2012US20120258086 Platelet solution for use in joint surgery
10/11/2012US20120258080 Pyridopyrazine derivatives and their use
10/11/2012US20120258079 Treatment and Prevention of Dengue Virus Infections
10/11/2012US20120258078 Antiviral compounds of three linked aryl moieties to treat diseases such as hepatitis c
10/11/2012US20120258077 Human M2e Peptide Immunogens
10/11/2012US20120258076 Method for characterizing host immune funtion by ex vivo induction of offensive and defensive immune markers
10/11/2012US20120258075 Methods of neuroprotection involving macrophage colony stimulating factor receptor agonists
10/11/2012US20120258074 Systems, Models and Methods for Identifying and Evaluating Skin-Active Agents Effective for Treating Dandruff/Seborrheic Dermatitis
10/11/2012US20120258072 Interleukin-11 Fusion Proteins
10/11/2012US20120258071 Compositions and Methods of Use for MGD-CSF in Disease Treatment
10/11/2012US20120258070 Methods and Compositions for Promoting Organ Development
10/11/2012US20120258057 Silicone organic elastomer gels from organopolysiloxane resins
10/11/2012US20120258047 Epsilon-poly-lysine capsules
10/11/2012US20120258043 Linkable Lewis X Analogs
10/11/2012US20120258038 Uses of apoptotic cell-targeting peptides, label substances and liposomes containing a therapeutic agent for preventing, treating or therapeutically diagnosing apoptosis-related diseases
10/11/2012DE112009003659T5 Mittel zur Beseitigung einer Multiarzneimitelresistenz Means for removing a multidrug resistance Mitel
10/11/2012CA2832665A1 Method for producing injectable formulations of blood-derived protein materials, and materials obtained using said method
10/11/2012CA2832581A1 Method of treating or ameliorating metabolic disorders using growth differentiation factor 15 (gdf-15)
10/11/2012CA2832534A1 Method for the generation of compact tale-nucleases and uses thereof
10/11/2012CA2832487A1 Macrophage activating factor for pharmaceutical compositions
10/11/2012CA2832486A1 Ophthalmic preparations based on pacap (pituitary adenylate cyclase activating polypeptide) which restore the normal visual function in early glaucoma
10/11/2012CA2832443A1 Modulating bacterial mam polypeptides in pathogenic disease
10/11/2012CA2832401A1 Thixotropic .alpha.-lactalbumin hydrogels, method for preparing same and uses thereof
10/11/2012CA2832376A1 Drug containing recombinant mistletoe lectins for treating malignant melanoma
10/11/2012CA2832260A1 Method for treating ifnalpha related conditions
10/11/2012CA2832225A1 Tam receptor ligands, metabolites and precursors thereof in the detection and modulation of inflammatory neuropathological disease
10/11/2012CA2832115A1 Pepducin design and use
10/11/2012CA2832113A1 Hepatocyte growth factor mimics as therapeutic agents
10/11/2012CA2832092A1 Bpi and its congeners as radiation mitigators and radiation protectors
10/11/2012CA2831707A1 Use of a hypoallergenic cereal composition for inducing specific oral tolerance
10/11/2012CA2831535A1 Oral enzyme compositions for intestinal delivery
10/11/2012CA2830372A1 Long-acting peptide analogs
10/11/2012CA2830013A1 Recombinant polypeptide production method
10/10/2012EP2508606A1 Partial fragment of REIC/Dkk-3 gene and therapeutic agent for cancer containing the same
10/10/2012EP2508599A1 Retrograde transport viral vector system having envelope comprising fused glycoprotein
10/10/2012EP2508200A1 Carbonic anhydrase i serving as novel antigen to be used for treatment of autoimmune diseases
10/10/2012EP2508199A1 Melanocyte-stimulation hormone for suppressing inflammation reactions in hemodialysis
10/10/2012EP2508198A1 Peptides for suppressing inflammation reactions in hemodialysis
10/10/2012EP2508197A1 Method for treating IFNalpha related conditions
10/10/2012EP2508196A1 Use of PEDF-derived polypeptides for promoting stem cells proliferation and wound healing
10/10/2012EP2508195A1 Medicine containing recombinant mistellectins for treating malignant melanoma
10/10/2012EP2508194A1 Methods of treating disease with random copolymers
10/10/2012EP2508193A1 Use of a hypoallergenic cereal composition for inducing specific oral tolerance
10/10/2012EP2508176A1 Novel combination treatment of cancer
10/10/2012EP2507267A1 Compositions and methods for increasing serum half-life of fc fusion proteins
10/10/2012EP2507266A2 TREATMENT OF IgE-MEDIATED DISEASE
10/10/2012EP2507261A1 Fibronectin: growth factor chimeras
10/10/2012EP2507255A1 Peptides binding to the dimer interface of thymidylate synthase for the treatment of cancer
10/10/2012EP2506874A1 Von willebrand factor specific binding agents and uses thereof
10/10/2012EP2506871A1 ANTIBODY Fc MUTANTS WITH ABLATED EFFECTOR FUNCTIONS
10/10/2012EP2506869A1 Arf6 as a new target for treating alzheimer's disease
10/10/2012EP2506868A2 Factor viii-fc chimeric and hybrid polypeptides, and methods of use thereof
10/10/2012EP2506867A1 Pharmaceutical compositions for the stimulation of stem cells.
10/10/2012EP2506866A2 Treatment of nerve injuries
10/10/2012EP2506865A2 Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
10/10/2012EP2506864A1 Treatment and prevention of cancers associated with intracellular oncoproteins by antibody therapy or vaccination
10/10/2012EP2506863A1 Method of regulating ppar, obesity related pathways and their associated metabolic impact
10/10/2012EP2506862A1 Composition and methods for the prevention and treatment of macular degeneration, diabetic retinopathy, and diabetic macular edema
10/10/2012EP2506861A1 Binding proteins that bind to human fgfr1c, human b-klotho and both human fgfr1c and human b-klotho
10/10/2012EP2506839A2 Transdermal therapeutic system for the administration of peptides
10/10/2012EP2506717A1 Method of using dopamine reuptake inhibitors and their analogs for treating diabetes symptoms and delaying or preventing diabetes-associated pathologic conditions
10/10/2012EP2263654B1 Compositions for improving the oral absorption of antimicrobial agents
10/10/2012CN1973053B Novel anti-IL 13 antibodies and uses thereof
10/10/2012CN1953989B Camptothecins conjugated in position 7 to cyclic peptides as cytostatic agents
10/10/2012CN1822817B Inhalable formulations for treating pulmonary hypertension and methods of using same
10/10/2012CN1798841B Complement inhibitors from ticks
10/10/2012CN1714861B Thymus penta peptide slow releasing micro ball and its preparing method
10/10/2012CN1678188B Nucleic acid compositions for stimulating immune responses
10/10/2012CN1662251B Adjuvant enhanced immunotherapy
10/10/2012CN1625566B Lactoferrin
10/10/2012CN1622821B Method of stimulating growth and resistance to diseases of aquatic organisms
10/10/2012CN1607957B Modulation of excitable tissue function by peripherally administered erythropoietin
10/10/2012CN1522156B Novel engineered superantigen for human therapy
10/10/2012CN1501809B Chronic treatment regimen using glucagon-like insulinotropic peptides
10/10/2012CN1371416B Human CTLA-4 antibodies and their uses
10/10/2012CN1359301B Pharmaceutical composition comprising antibody specifically binding epitope in A-beta-10 residual group and its application
10/10/2012CN1304450B Novel insulin analogs with enhanced zinc binding
1 ... 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 ... 3163